Our Offering
Biologics
Mammalian
Microbial
ADCs / Bioconjugates
Drug Product
mRNA / LNP
Expression Technologies
Small Molecules
Drug Substance (API)
Particle Engineering
Drug Product
Cell & Gene
Process Development
cGMP manufacturing
Allogeneic
Autologous
Viral Vectors
Bioscience Products
Capsules & Health Ingredients
Health Ingredients
Nutraceutical capsules
Pharmaceutical capsules
Capsule filling equipment
Our Company
About Us
Purpose and Strategy
Leadership
History
Locations
Events
News and Media
News Archive
Media Library
Logo Guidelines
Blog
Podcast
Media Inquiries
Investor Relations
Shareholder Information
Agenda and Events
Financial Reporting
Annual Report
Corporate Governance
Ethics and Compliance
Investor Inquiries
Sustainability
Performance
People
Planet
Community
Global Quality
Responsible Sourcing
Careers
Overview
Life at Lonza
What We Offer
Career Stories
Job Search
Join Our Talent Community
Recruitment Process
Students, Graduates and Apprentices
Contact
Trending Topics
Expanded CGT Process Development Laboratories in the US & EU
Trending Topics
Expanded CGT Process Development Laboratories in the US & EU
Our Offering
Corporate
Biologics
Mammalian
Microbial
ADCs / Bioconjugates
Drug Product
mRNA / LNP
Expression Technologies
Small Molecules
Drug Substance (API)
Particle Engineering
Drug Product
Cell & Gene
Process Development
cGMP manufacturing
Allogeneic
Autologous
Viral Vectors
Bioscience Products
Capsules & Health Ingredients
Health Ingredients
Nutraceutical capsules
Pharmaceutical capsules
Capsule filling equipment
Our Company
Corporate
About Us
Purpose and Strategy
Leadership
History
Locations
Events
News and Media
News Archive
Media Library
Logo Guidelines
Blog
Podcast
Media Inquiries
Investor Relations
Shareholder Information
Agenda and Events
Financial Reporting
Annual Report
Corporate Governance
Ethics and Compliance
Investor Inquiries
Sustainability
Performance
People
Planet
Community
Global Quality
Responsible Sourcing
Careers
Corporate
Overview
Life at Lonza
What We Offer
Career Stories
Job Search
Join Our Talent Community
Recruitment Process
Students, Graduates and Apprentices
Contact
Corporate
Home
Knowledge Center
Human-Induced Pluripotent Stem Cells Manufactured
Human-Induced Pluripotent Stem Cells Manufactured
28 Feb 2018 | Content Type: Peer-reviewed publication
Frontiers in Medicine peer-reviewed paper on hIPSCs cGMP manufacturing.
First Name
Last Name
Business Email
Company Name
Join our community to receive tailored insights and resources. You can unsubscribe at any time.
By clicking "Access Content" you agree to our
Legal Disclaimer
and the
Lonza Privacy and Cookies Policy
.
Latest content
Latest briefing from the Knowledge Center
Article
De-Risk Biologics’ Expression and Manufacturing Through Early In Silico and In Vitro Assessments
Drug development has become increasingly competitive and leaves little room for error or delay....
Poster
Novel engineered plasmids and optimized HEK293 cell line improves AAV productivity
Gene therapy developers are under increasing pressure to advance their AAV-based therapeutics for...
Article
Ramp up your AAV productivity with novel engineered plasmids and optimized HEK293 cell lines
Lonza has established experience and capabilities in rAAV production and is continually identifying...
Whitepaper/Executive Summary
Lonza Shapes Biotherapeutics Development Programs Around Different CMC Paths
As protein engineering and manufacturing technologies evolve, small biotech and major pharma...
Whitepaper/Executive Summary
Flexibility Is A Critical Aspect Of Biotech-CDMO Relationships
The Lonza small biotech series highlights the critical components that smaller innovators need to...
Whitepaper/Executive Summary
Accessibility Is A Key Difference In Biotech-CDMO Relationships
The Lonza small biotech series highlights the critical components that innovative Biotechs need to...
Whitepaper/Executive Summary
Communication Is A Foundation For Effective Biotech-CDMO Relationships
The Lonza small biotech series highlights the critical components that smaller innovators need to...
Presentation (on-demand)
Process development for CGT: How soon is too soon? (Geleen)
During the inaugural event of expanded Process and Analytical Development Laboratories at Lonza...
R&D Blog post
Why is an integrated service offering so important for the modern pharmaceutical industry?
I am often asked why I believe an integrated service offering is so important for the pharmaceutical...
Webinar (on-demand)
CMC and CDMO: The Importance of Choosing the Right Partner
Small pharma companies are driving pipeline innovation and are increasingly taking more complex...
Whitepaper/Executive Summary
How Can You Ensure Successful Late-Phase Development And Launch Of Your Biologic Drug Product?
Biologics, which are expected to account for over half of all innovative drug sales by 2027, offer...
Video
Erik Lemay, Servier Video Testimonial
In this video, Erik Lemay, Head of Global External manufacturing at Servier discusses the...
Previous
Next